Skip to main content
Breast Ki67AI
Ki67 IHC digital slide (left) with Breast Ki67 AI markup (right) identifying negative (blue) and positive (red) cells. Tumor boundary highlighted with red lines.

Breast Ki67 AI

Developed by Indica Labs, the Breast Ki67 AI solution leverages deep learning that standardizes scoring of Ki67 in resections, excisions, or biopsies from primary invasive breast cancer samples. The algorithm reports quantitative results and markup images, including tumor detection and percent positive Ki67 cells.

Activate AI Now

Contattaci

Breast Ki67 AI is For Research Use Only and not intended for clinical diagnostic use. Breast Ki67 AI accessed via the Aperio HALO AP image management system.

indica-lab-logo

Breast Ki67 AI in Aperio HALO AP Demonstration 

Explore the future of pathology with the Breast Ki67 AI app from Indica Labs. Breast Ki67 AI seamlessly integrates within the Aperio HALO AP enterprise digital pathology platform to identify Ki67 tumor cells in primary invasive breast cancer samples.

After selecting an image, view the IHC slide in the viewer and the Breast Ki67 AI results. Results include overlays and quantitative results. The first set of overlays prepare the tissue for analysis by identifying areas of analyzable tissue. The next overlay identifies areas of tumor in the tissue. The final overlay identifies and classifies cells for Ki67 positivity within the tumor area. Finally, quantitative results at a per slide level are displayed in the assay panel to the right.

Leica Biosystems file download

Documents